Philip Kantoff

Co-Founder & Chief Executive Officer at Convergent Therapeutics, Inc. - Cambridge, Massachusetts, United States

Philip Kantoff's Colleagues at Convergent Therapeutics, Inc.
Philip Kantoff's Contact Details
HQ
Location
Newton,Massachusetts,United States
Company
Convergent Therapeutics, Inc.
Philip Kantoff's Company Details
Convergent Therapeutics, Inc. logo, Convergent Therapeutics, Inc. contact details

Convergent Therapeutics, Inc.

Cambridge, Massachusetts, United States • 4 Employees
Research

Convergent Therapeutics is a clinical-stage biotechnology company exploring the full potential of dual-targeted combination strategies to treat cancer. Convergent has developed a therapeutic platform that is capable of targeting validated and novel cancer antigens. Building on breakthrough research developed by Dr. Neil Bander at Weill Cornell Medicine, Convergent has demonstrated that dual targeting of surface cancer molecules like Prostate-Specific Membrane Antigen (PSMA) improves antitumor efficacy. By leveraging targeting agents with different bio-distributions, such as monoclonal antibodies and ligands, supra-additive therapeutic doses are delivered to tumor cells without additive toxicity to the patient.

Details about Convergent Therapeutics, Inc.
Frequently Asked Questions about Philip Kantoff
Philip Kantoff currently works for Convergent Therapeutics, Inc..
Philip Kantoff's role at Convergent Therapeutics, Inc. is Co-Founder & Chief Executive Officer.
Philip Kantoff's email address is ***@convergentrx.com. To view Philip Kantoff's full email address, please signup to ConnectPlex.
Philip Kantoff works in the Research industry.
Philip Kantoff's colleagues at Convergent Therapeutics, Inc. are and others.
Philip Kantoff's phone number is
See more information about Philip Kantoff